Analysis and Commentary 1/23/15 Analysis and Commentary 1/23/15 Impact of Precision Medicine Initiative on FDA Read More Analysis and Commentary 1/16/15 Analysis and Commentary 1/16/15 The BCA and the FY 16 Budget "Squeeze" Read More Analysis and Commentary 1/10/15 Analysis and Commentary 1/10/15 Predictability and uncertainty in 2015 Read More Analysis and Commentary 12/18/14 Analysis and Commentary 12/18/14 FY 2016: Out with the Old; In with the New Read More Analysis and Commentary 12/5/14 Analysis and Commentary 12/5/14 Why Unfunded Mandates Can Be a Real Problem for FDA Read More Analysis and Commentary 11/20/14 Analysis and Commentary 11/20/14 "Turkey Day" ... and an Expression of Gratitude Read More Analysis and Commentary 11/14/14 Analysis and Commentary 11/14/14 "Fiscal Cliffs" and Life in "Interesting Times" Read More Analysis and Commentary 11/6/14 Analysis and Commentary 11/6/14 Change Is Unsettling ... But Our Message Remains the Same Read More Analysis and Commentary 10/30/14 Analysis and Commentary 10/30/14 Planning for a Late Night Watching "the Box" Read More Analysis and Commentary 10/24/14 Analysis and Commentary 10/24/14 FDA Can't Just Pare Back Without Risk for Harm Read More Analysis and Commentary 10/18/14 Analysis and Commentary 10/18/14 Appropriators Are the First Priority, But ... Read More Analysis and Commentary 10/9/14 Analysis and Commentary 10/9/14 When Tough Choices Get Made, FDA Will Prevail Read More Analysis and Commentary 10/3/14 Analysis and Commentary 10/3/14 Good ... But Not Good Enough! Read More Analysis and Commentary 9/26/14 Analysis and Commentary 9/26/14 An X-Like Prize for Regulatory Science Read More Analysis and Commentary 9/19/14 Analysis and Commentary 9/19/14 What May the Road Look Like Come November? Read More Analysis and Commentary 9/12/14 Analysis and Commentary 9/12/14 Agency Growth ... And Macro-Budgetary Politics Read More Analysis and Commentary 3/1/13 Analysis and Commentary 3/1/13 And So It Begins ... Read More Analysis and Commentary 2/25/13 Analysis and Commentary 2/25/13 Sequestration and Its Consequences -- A Short Q&A Read More Analysis and Commentary 2/15/13 Analysis and Commentary 2/15/13 Chaos, Dysfunction, and Two Certainties Read More Analysis and Commentary 2/8/13 Analysis and Commentary 2/8/13 Alliance Still Committed to Protecting FDA from Sequestration Read More Newer Posts Older Posts
Analysis and Commentary 1/23/15 Analysis and Commentary 1/23/15 Impact of Precision Medicine Initiative on FDA Read More
Analysis and Commentary 1/16/15 Analysis and Commentary 1/16/15 The BCA and the FY 16 Budget "Squeeze" Read More
Analysis and Commentary 1/10/15 Analysis and Commentary 1/10/15 Predictability and uncertainty in 2015 Read More
Analysis and Commentary 12/18/14 Analysis and Commentary 12/18/14 FY 2016: Out with the Old; In with the New Read More
Analysis and Commentary 12/5/14 Analysis and Commentary 12/5/14 Why Unfunded Mandates Can Be a Real Problem for FDA Read More
Analysis and Commentary 11/20/14 Analysis and Commentary 11/20/14 "Turkey Day" ... and an Expression of Gratitude Read More
Analysis and Commentary 11/14/14 Analysis and Commentary 11/14/14 "Fiscal Cliffs" and Life in "Interesting Times" Read More
Analysis and Commentary 11/6/14 Analysis and Commentary 11/6/14 Change Is Unsettling ... But Our Message Remains the Same Read More
Analysis and Commentary 10/30/14 Analysis and Commentary 10/30/14 Planning for a Late Night Watching "the Box" Read More
Analysis and Commentary 10/24/14 Analysis and Commentary 10/24/14 FDA Can't Just Pare Back Without Risk for Harm Read More
Analysis and Commentary 10/18/14 Analysis and Commentary 10/18/14 Appropriators Are the First Priority, But ... Read More
Analysis and Commentary 10/9/14 Analysis and Commentary 10/9/14 When Tough Choices Get Made, FDA Will Prevail Read More
Analysis and Commentary 10/3/14 Analysis and Commentary 10/3/14 Good ... But Not Good Enough! Read More
Analysis and Commentary 9/26/14 Analysis and Commentary 9/26/14 An X-Like Prize for Regulatory Science Read More
Analysis and Commentary 9/19/14 Analysis and Commentary 9/19/14 What May the Road Look Like Come November? Read More
Analysis and Commentary 9/12/14 Analysis and Commentary 9/12/14 Agency Growth ... And Macro-Budgetary Politics Read More
Analysis and Commentary 2/25/13 Analysis and Commentary 2/25/13 Sequestration and Its Consequences -- A Short Q&A Read More
Analysis and Commentary 2/15/13 Analysis and Commentary 2/15/13 Chaos, Dysfunction, and Two Certainties Read More
Analysis and Commentary 2/8/13 Analysis and Commentary 2/8/13 Alliance Still Committed to Protecting FDA from Sequestration Read More
